Haemonetics Corp. (HAE)
118.28
-3.01
(-2.48%)
USD |
NYSE |
Oct 16, 16:00
118.38
+0.10
(+0.08%)
Pre-Market: 20:00
Haemonetics Enterprise Value : 6.329B for Oct. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 16, 2026 | 6.329B |
| October 15, 2026 | 6.466B |
| October 14, 2026 | 6.458B |
| October 13, 2026 | 6.486B |
| October 12, 2026 | 6.501B |
| October 09, 2026 | 6.348B |
| October 08, 2026 | 6.383B |
| October 07, 2026 | 5.576B |
| October 06, 2026 | 5.658B |
| October 05, 2026 | 5.711B |
| October 02, 2026 | 5.711B |
| October 01, 2026 | 5.697B |
| September 30, 2026 | 5.739B |
| September 29, 2026 | 5.762B |
| September 28, 2026 | 5.761B |
| September 25, 2026 | 5.739B |
| September 24, 2026 | 5.771B |
| September 23, 2026 | 5.808B |
| September 22, 2026 | 5.885B |
| September 21, 2026 | 5.895B |
| September 18, 2026 | 5.880B |
| September 17, 2026 | 5.843B |
| September 16, 2026 | 5.782B |
| September 15, 2026 | 5.780B |
| September 14, 2026 | 5.785B |
| Date | Value |
|---|---|
| September 11, 2026 | 5.620B |
| September 10, 2026 | 5.546B |
| September 09, 2026 | 5.642B |
| September 08, 2026 | 5.627B |
| September 04, 2026 | 5.631B |
| September 03, 2026 | 5.627B |
| September 02, 2026 | 5.631B |
| September 01, 2026 | 5.587B |
| August 31, 2026 | 5.638B |
| August 28, 2026 | 5.678B |
| August 27, 2026 | 5.725B |
| August 26, 2026 | 5.798B |
| August 25, 2026 | 5.876B |
| August 24, 2026 | 5.880B |
| August 21, 2026 | 5.898B |
| August 20, 2026 | 5.872B |
| August 19, 2026 | 5.880B |
| August 18, 2026 | 5.709B |
| August 17, 2026 | 5.055B |
| August 14, 2026 | 5.080B |
| August 13, 2026 | 5.060B |
| August 12, 2026 | 5.104B |
| August 11, 2026 | 4.917B |
| August 10, 2026 | 4.889B |
| August 07, 2026 | 4.945B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 9.815B |
| Abbott Laboratories | 209.16B |
| ICU Medical, Inc. | 5.065B |
| Merit Medical Systems, Inc. | 5.695B |
| Teleflex, Inc. | 8.084B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 33.01M |
| Revenue (Quarterly) | 339.38M |
| Total Expenses (Quarterly) | 306.37M |
| EPS Diluted (Quarterly) | 0.7223 |
| Gross Profit Margin (Quarterly) | 56.98% |
| Profit Margin (Quarterly) | 9.73% |
| Earnings Yield | 1.73% |
| Operating Earnings Yield | 4.50% |
| Normalized Earnings Yield | 2.826 |